ANGO Financial Facts

Interest income: 4K
Cost of sales: 43.07M
See Full Income Statement

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY: 726.71M
TOTAL ASSETS: 726.71M
See Full Balance Sheet

AngioDynamics (ANGO) Earnings

  |   Expand Research on ANGO
Next EPS Date 4/7/17 *Est. EPS Growth Rate +164.3% *Last Qtr.
Average EPS % Beat Rate +39.3% Revenue Growth Rate -0.2% *Last Qtr.
Average % Move 1-Wk after EPS +14.3% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
1/6/17 Q217 $0.37$0.16 +$0.21$89M$91.09M = Details
10/5/16 Q117 $0.17N/A N/A $88.1M$83.8M = Details
7/13/16 Q416 $0.19$0.16 +$0.03$93.4M$88.41M = Details
4/7/16 Q316 $0.15$0.14 +$0.01$87.4M$85.07M = Details
1/7/16 Q216 $0.14$0.14 $0.00$89.2M$88.67M = Details
10/8/15 Q116 $0.11$0.11 $0.00$83.7M$84.7M = Details
7/16/15 Q415 $0.14$0.14 $0.00$90.9M$91.67M = Details
4/9/15 Q315 $0.12$0.16 -$0.04$86.6M$89.8M Details